within Pharmacolibrary.Drugs.H_SystemicHormonalPreparationsExclSexHormonesAndInsulins.H02A_CorticosteroidsForSystemicUsePlain.H02AB04_Methylprednisolone;

model Methylprednisolone_1
  extends Pharmacolibrary.Pharmacokinetic.Models.PK_1C_enteral(
    weight = 70,
    F = 0.82,
    Cl = 3.4611111111111108e-06,
    adminDuration = 600,
    adminMass = 24 / 1000000,
    adminCount = 1,
    Vd = 0.00138,
    Cmin = 0.001,
    Cmax = 0.01,
    Ctox_peak = 0.02,
    Ctox_trough = 0.01,
    ka = 0.028666666666666667,
    Tlag = 600);

  annotation (Documentation(
    info       = "<html><body><table><tr><td>name:</td><td>Methylprednisolone_1</td></tr><tr><td>ATC code:</td><td>H02AB04_1</td></tr><td>route:</td><td>oral</td></tr>
    <tr><td>compartments:</td><td>1</td></tr>
    <tr><td>dosage:</td><td>24</td><td>mg</td></tr>
    <tr><td>volume of distribution:</td><td>1.38</td><td>L</td></tr>
    <tr><td>clearance:</td><td>0.178</td><td>L/h/kg</td></tr>
    <tr><td colspan='3'>other parameters in model implementation</td></tr>
    </table><p>Methylprednisolone is a synthetic glucocorticoid corticosteroid drug with potent anti-inflammatory and immunosuppressive properties. It is widely used to treat conditions such as allergic reactions, autoimmune diseases, certain types of arthritis, and is also employed in transplant rejection prophylaxis. It is approved and commonly used in clinical practice today.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters after single oral dose in healthy adult male volunteers.</p><h4>References</h4><ol><li><p>Wang, DD, et al., &amp; Li, ZP (2018). Population pharmacokinetics of tacrolimus in paediatric systemic lupus erythematosus based on real-world study. <i>Journal of clinical pharmacy and therapeutics</i> 43(4) 476–483. DOI:<a href=\"https://doi.org/10.1111/jcpt.12707\">10.1111/jcpt.12707</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/29766530/\">https://pubmed.ncbi.nlm.nih.gov/29766530</a></p></li><li><p>Tornatore, KM, et al., &amp; Venuto, RC (1995). Methylprednisolone pharmacokinetics, cortisol response, and adverse effects in black and white renal transplant recipients. <i>Transplantation</i> 59(5) 729–736. DOI:<a href=\"https://doi.org/10.1097/00007890-199503150-00016\">10.1097/00007890-199503150-00016</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/7886801/\">https://pubmed.ncbi.nlm.nih.gov/7886801</a></p></li><li><p>Mehta, J, et al., &amp; Kaushik, NK (2022). Role of Dexamethasone and Methylprednisolone Corticosteroids in Coronavirus Disease 2019 Hospitalized Patients: A Review. <i>Frontiers in microbiology</i> 13 813358–None. DOI:<a href=\"https://doi.org/10.3389/fmicb.2022.813358\">10.3389/fmicb.2022.813358</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/35242118/\">https://pubmed.ncbi.nlm.nih.gov/35242118</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>10/2026 Pharmacolibrary 26.09: model of Drugs.ATC.H.H02AB04_1 folded in (Drugs.ATC removed)</li><li>06/2025 Tomas Kulhanek, generated model from data extracted from PUBMED, DrugBank and LLM(GPT4.1)</li></ul></body></html>",
    experiment (StartTime = 0, StopTime = 86400, Tolerance = 1e-9, Interval = 1)
  ));
    
end Methylprednisolone_1;
